Last week, the U.S. Food and Drug Administration announced a voluntary recall of Nova Max Blood Glucose Test Strips that may report a false, abnormally high blood glucose result.
The FDA stated in a news release that “under certain conditions, a false, abnormally high blood glucose level could result in an insulin dosing error, requiring the user to seek immediate medical attention.”
It has been reported that nearly 62 million strips may be affected by this recall. The faulty supply was produced from December 2011 to April 2013 and unfortunately became contaminated with a chemical used during the manufacturing process.
Marketed under brand names such as Nova Max Blood Glucose Test Strips and Nova Max Plus Glucose Meter Kits, this recall concerns countries across the globe. The FDA is working in conjunction with Nova Diabetes Care, the manufacturer of these strips, to prevent incidents such as this from happening in the future.
The FDA recommends that patients:
- Check to confirm if they have blood glucose test strips from the affected lots and immediately discontinue use of the recalled strips and take the necessary steps to continue to monitor blood sugar.
- Pay special attention to signs and symptoms of high and low blood sugar.
You should consult with a doctor if you have any ongoing symptoms or health concerns. You should also consult with a Lopez McHugh attorney if you or a loved one have experienced harm or delay in critical care from using Nova Max Blood Glucose Test Strips.
